Example: Heart Attack

Search clinical trials for: Adrenergic beta-Agonists

Total 1734 results

NCT02885636

Completed

Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial

Conditions: Congestive Heart Failure; Heart Failure, Left-Sided; Left-Sided Heart Failure
NCT01209715

Withdrawn

Effect of an Inhaled Glucocorticoid-long-acting Beta Adrenergic Agonist on Endothelial Function in COPD

Conditions: COPD
NCT00000577

Withdrawn

Asthma Clinical Research Network (ACRN)

Conditions: Asthma; Lung Diseases
NCT01725360

Completed

Change of Airway Hyperresponsiveness to Mannitol and Methacholine in Patients With Asthma

Conditions: Asthma
NCT00785083

Completed

A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate Asthma

Conditions: Asthma
NCT00624416

Completed

Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas

Conditions: Lipoma
NCT01238432

Active, not recruiting

The Genetics of Severe Asthma in Children

Conditions: Asthma
NCT00570297

Active, not recruiting

Genetic Influences of Albuterol Response In Children With Bronchiolitis

Conditions: Bronchiolitis
NCT03788057

Unknown status

Inflammatory Indices in Predicting the Failure of Inhaled Corticosteroids Reduction in Young Participants With Asthma

Conditions: Asthma Chronic
NCT00585546

Terminated

Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure

Conditions: Heart Failure; Dilated Cardiomyopathy
NCT01440335

Completed

Initial Study of Fenoterol as a Treatment for Heart Failure

Conditions: Congestive Heart Failure
NCT03383588

Terminated

Subcutaneous Bupivacaine Decrease Post-op Pain in Patients Undergoing C-Section

Conditions: Pain, Referred
NCT00160056

Completed

The Effect of Antecedent Hypoglycaemia on β2-adrenergic Sensitivity

Conditions: Diabetes; Hypoglycemia Unawareness
NCT02725060

Enrolling by invitation

Autoimmune Basis for Postural Tachycardia Syndrome

Conditions: Postural Orthostatic Tachycardia Syndrome; Postural Tachycardia Syndrome; Tachycardia; Arrhythmias, Cardiac; Autonomic Nervous System Diseases; Orthostatic Intolerance; Cardiovascular Diseases; Primary Dysautonomias
NCT01783470

Completed

Effects of b3-Adrenergic Receptor Agonists on Brown Adipose Tissue

Conditions: Obesity
NCT00567476

Completed

Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma

Conditions: Asthma
NCT00855530

Completed

Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder

Conditions: Major Depressive Disorders
NCT00535340

Terminated

An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Generalized Anxiety Disorder

Conditions: Anxiety Disorders
NCT00397098

Terminated

Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder

Conditions: Anxiety Disorders
NCT00385307

Completed

Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)

Conditions: Major Depressive Disorder
NCT00345098

Completed

A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder

Conditions: Depressive Disorder; Major Depression
NCT00332891

Completed

An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder

Conditions: Anxiety Disorders
NCT00319709

Completed

An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Depression

Conditions: Depressive Disorder
NCT00266747

Completed

An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder

Conditions: Anxiety Disorders
NCT00252356

Completed

Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder

Conditions: Major Depressive Disorder